ATORVASTATIN CALCIUM
- Product NDC
- 61919-258
- 11-digit product format
- 619190258
- Labeler code
- 61919
- Product ID
- 61919-258_f21263ee-3266-b481-e053-2995a90a6554
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA091650
- Marketing category
- ANDA
- Marketing start
- 2015-01-01
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fa898d56-9495-d6f0-309b-68a5d8e3914a | Product name | 4 | 20260305 |
| fb7ab793-2c12-4079-b100-a64f73bef25a | Product name | 4 | 20240712 |
| d25cba4b-d79e-4890-8837-1382f7d09489 | Product name | 1 | 20231002 |
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| 91774e91-b249-45e3-8ff8-4b5db2927a69 | Product name | 1 | 20230718 |
| b0cbf770-6cc3-4aa4-9158-755110c2b9f7 | Product name | 2 | 20230717 |
| dc7c5daa-021f-40dd-b00d-63982cb2067a | Product name | 1 | 20230426 |
| 03fb3cda-d60a-4873-94e9-6fa77cfb1a1c | Product name | 1 | 20220302 |
| 34152997-af0b-acf4-dcaf-37211afe8ca4 | Product name | 9 | 20210312 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 5 | 20200925 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 2 | 20160823 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| 46fdf265-6d5a-1bfb-93db-d82a4ea8aa81 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61919-258-30 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8dcf-d83d-e063-dadaa90ab31f | ATORVASTATIN CALCIUM |
| 61919-258-90 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8dcf-d83d-e063-dadaa90ab31f | ATORVASTATIN CALCIUM |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61919-258-30 | ATORVASTATIN CALCIUM | 30 in 1 BOTTLE | TABLET | 30 | 6 | |
| 61919-258-90 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE | TABLET | 90 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61919-258-30 | EA - Each | 61919-258 | 702eda7f-9c09-4b56-b87b-069743d66a8f | 1 | 2016-02-04 |
| 61919-258-90 | EA - Each | 61919-258 | 85dc87ea-e87b-422e-889b-19cb10feed7c | 1 | 2019-11-12 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 617310 | atorvastatin calcium 20 MG Oral Tablet | PSN | 33b2b42d-60b1-47df-9df9-9965e13ece9f | 6 |
| 617310 | atorvastatin 20 MG Oral Tablet | SCD | 33b2b42d-60b1-47df-9df9-9965e13ece9f | 6 |
| 617310 | atorvastatin (as atorvastatin calcium) 20 MG Oral Tablet | SY | 33b2b42d-60b1-47df-9df9-9965e13ece9f | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 61919-258-30 | 61919025830 | 30 TABLET in 1 BOTTLE (61919-258-30) | 30 tablet | 2019-09-19 | 0000-00-00 | No | No | Current |
| 61919-258-90 | 61919025890 | 90 TABLET in 1 BOTTLE (61919-258-90) | 90 tablet | 2015-01-01 | 0000-00-00 | No | No | Current |